News

Antibiotic resistance: How CARB-X helps new companies get a running start

Antibiotic resistance: How CARB-X helps new companies get a running start

THE STATE OF HEALTH WITH GUNNAR ESIASON PODCAST | Gunnar Esiason, a patient advocate, host of The State of Health podcast series, and Chief Strategy Officer of the Boomer Esiason Foundation, talks with CARB-X Executive Director Kevin Outterson about the early-stage landscape for companies developing antibiotics. The conversation also delves into the PASTEUR and DISARM Acts, the current US legislature aimed at fixing the broken antibiotic market. Listen to learn more.

Full Story